Kheiron Medical Technologies is an AI diagnostics company focused on transforming cancer care. The company is initially focused on breast cancer screening.
Kheiron Medical's mission is to help breast cancer patients live longer, better lives through earlier detection.
Kheiron Medical was founded in 2016 by Dr. Peter Kecskemethy and Tobias Rijken. The company is headquartered in London, London, United Kingdom.
Kheiron combines novel deep learning methods, data science, and radiology expertise to enable an entirely new level of diagnostics that are designed to detect cancers and give every patient a better fighting chance against the disease.
Kheiron offers a breast-screening product called Mia™, a breast cancer screening solution that supports radiologists in reducing errors in breast cancer detection. Mia™ is the proud winner of the 'Best New Radiology Software 2019 ' award by Aunt Minnie Europe.
Kheiron's Mia™, or mammography intelligent assessment, is designed to analyze standard FFDM mammograms in a breast cancer screening setting. It is the first product developed by a UK company to receive the CE mark for deep learning software in radiology.
Kheiron is backed by Atomico, Greycroft, Connect Ventures, Hoxton Ventures, and Exor Seeds. The company raised $22M from its "Series A" financing on Sep 23, 2019. The round brings Kheiron's total funding to $22.95M to date.